Predictions
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.38
28.06.21
28.06.21
€2.50
28.06.22
28.06.22
-71.16%
29.06.22
29.06.22
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.26
12.06.21
12.06.21
€1.00
12.06.22
12.06.22
-14.11%
26.06.21
26.06.21
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.64
01.05.21
01.05.21
€4.50
01.05.22
01.05.22
-30.60%
11.06.21
11.06.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€5.50
24.03.21
24.03.21
€5.50
24.03.22
24.03.22
-15.64%
01.05.21
01.05.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.99
15.01.21
15.01.21
-
4.50%
05.02.21
05.02.21
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.75
19.11.20
19.11.20
€2.90
19.11.21
19.11.21
-11.05%
10.07.21
10.07.21
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.55
16.11.20
16.11.20
€105.00
16.11.21
16.11.21
-10.40%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.45
16.11.20
16.11.20
-
16.11.21
16.11.21
-14.81%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.66
13.11.20
13.11.20
-
13.11.21
13.11.21
-33.13%
15.07.21
15.07.21
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€54.95
13.11.20
13.11.20
-
13.11.21
13.11.21
-40.00%
15.07.21
15.07.21
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€57.75
02.11.20
02.11.20
-
04.11.21
04.11.21
-4.85%
13.11.20
13.11.20
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.25
29.10.20
29.10.20
-
04.11.21
04.11.21
79.39%
15.07.21
15.07.21
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.53
28.10.20
28.10.20
€2.10
04.11.21
04.11.21
8.70%
19.11.20
19.11.20
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.65
22.10.20
22.10.20
-
29.10.20
29.10.20
-4.62%
29.10.20
29.10.20
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.76
13.10.20
13.10.20
€2.90
28.10.20
28.10.20
-8.43%
28.10.20
28.10.20
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Trillium Therapeutics
Start price
Target price
Perf. (%)
€11.70
02.10.20
02.10.20
-
04.11.21
04.11.21
-14.10%
10.12.20
10.12.20
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.90
01.10.20
01.10.20
-
02.11.20
02.11.20
-5.17%
02.11.20
02.11.20
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.10
15.09.20
15.09.20
-
22.10.20
22.10.20
-4.95%
22.10.20
22.10.20
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.99
10.09.20
10.09.20
-
04.11.21
04.11.21
11.67%
15.07.21
15.07.21
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€67.20
10.09.20
10.09.20
-
01.10.20
01.10.20
-9.38%
01.10.20
01.10.20
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€2.14
08.09.20
08.09.20
-
04.11.21
04.11.21
-22.43%
13.11.20
13.11.20
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
08.09.20
08.09.20
-
04.11.21
04.11.21
59.76%
05.11.21
05.11.21